Sunesis Pharmaceuticals Inc. (VIRX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
04-Mar-14 8:37 PM
View: 
Swisher Daniel N Jr
President and CEO
Director
Sunesis Pharmaceuticals Inc. (VIRX) 28-Feb-24Payment of Exercise 3,747$6.55$24,542.90(1%)
260.9K to 257.15K
27-Feb-24 7:54 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 27-Feb-24Option Sale 3,405$0.73$2,493.14(3%)
105.71K to 102.31K
27-Feb-24 7:58 PM
View: 
Royston Ivor
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Feb-24Option Exercise 25,219----3%
757.46K to 782.68K
27-Feb-24 7:56 PM
View: 
Pomerantz Roger
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Feb-24Option Exercise 9,034----10%
90.34K to 99.38K
27-Feb-24 7:54 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 25-Feb-24Option Exercise 6,889----7%
98.82K to 105.71K
04-Dec-23 4:54 PM
View: 
Rothera Mark
President and CEO
Director
Sunesis Pharmaceuticals Inc. (VIRX) 01-Dec-23Purchase 47,906$0.49$23,627.2092%
52.09K to 100.0K
04-Dec-23 4:54 PM
View: 
Rothera Mark
President and CEO
Director
Sunesis Pharmaceuticals Inc. (VIRX) 30-Nov-23Private Purchase 52,094$0.49$25,734.40100%
0 to 52.09K
28-Nov-23 7:06 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 28-Nov-23Option Sale 3,720$0.50$1,860.00(4%)
102.54K to 98.82K
28-Nov-23 7:01 PM
View: 
Pomerantz Roger
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Nov-23Option Exercise 9,034----11%
81.31K to 90.34K
28-Nov-23 7:06 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 25-Nov-23Option Exercise 6,889----7%
95.65K to 102.54K
28-Nov-23 7:03 PM
View: 
Royston Ivor
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Nov-23Option Exercise 25,219----3%
732.25K to 757.46K
29-Aug-23 6:47 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 28-Aug-23Option Sale 3,512$1.45$5,092.40(4%)
99.17K to 95.65K
29-Aug-23 6:47 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 25-Aug-23Option Exercise 6,888----7%
92.28K to 99.17K
29-Aug-23 6:52 PM
View: 
Royston Ivor
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Aug-23Option Exercise 25,219----4%
707.03K to 732.25K
29-Aug-23 6:49 PM
View: 
Pomerantz Roger
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Aug-23Option Exercise 9,034----12%
72.27K to 81.31K
26-May-23 7:32 PM
View: 
Royston Ivor
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-May-23Option Exercise 25,219----4%
681.81K to 707.03K
26-May-23 7:30 PM
View: 
Pomerantz Roger
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-May-23Option Exercise 9,035----14%
63.24K to 72.27K
26-May-23 7:29 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 25-May-23Option Sale 3,635$1.42$5,160.25(4%)
95.91K to 92.28K
26-May-23 7:29 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 25-May-23Option Exercise 6,889----8%
89.02K to 95.91K
28-Feb-23 6:22 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 27-Feb-23Option Sale 3,599$1.68$6,050.64(4%)
92.62K to 89.02K
28-Feb-23 6:28 PM
View: 
Rojkjaer Lisa
Chief Medical Officer
Sunesis Pharmaceuticals Inc. (VIRX) 27-Feb-23Option Sale 2,156$1.68$3,624.67(4%)
50.24K to 48.09K
28-Feb-23 6:25 PM
View: 
Pomerantz Roger
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Feb-23Option Exercise 9,034----17%
54.2K to 63.24K
28-Feb-23 6:22 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 25-Feb-23Option Exercise 6,889----8%
85.73K to 92.62K
28-Feb-23 6:28 PM
View: 
Rojkjaer Lisa
Chief Medical Officer
Sunesis Pharmaceuticals Inc. (VIRX) 25-Feb-23Option Exercise 4,127----9%
46.12K to 50.24K
28-Feb-23 6:30 PM
View: 
Royston Ivor
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Feb-23Option Exercise 25,219----4%
656.59K to 681.81K
29-Nov-22 5:33 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 28-Nov-22Option Sale 3,532$2.72$9,605.63(4%)
89.27K to 85.73K
29-Nov-22 5:25 PM
View: 
Rojkjaer Lisa
Chief Medical Officer
Sunesis Pharmaceuticals Inc. (VIRX) 28-Nov-22Option Sale 2,116$2.72$5,754.04(4%)
48.23K to 46.12K
29-Nov-22 5:25 PM
View: 
Rojkjaer Lisa
Chief Medical Officer
Sunesis Pharmaceuticals Inc. (VIRX) 25-Nov-22Option Exercise 4,127----9%
44.1K to 48.23K
29-Nov-22 5:18 PM
View: 
Royston Ivor
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Nov-22Option Exercise 25,219----4%
631.37K to 656.59K
29-Nov-22 5:21 PM
View: 
Pomerantz Roger
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Nov-22Option Exercise 9,034----20%
45.17K to 54.2K
29-Nov-22 5:33 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 25-Nov-22Option Exercise 6,889----8%
82.38K to 89.27K
29-Aug-22 9:11 PM
View: 
Royston Ivor
CEO & President
Director
Sunesis Pharmaceuticals Inc. (VIRX) 26-Aug-22Option Sale 13,379$4.01$53,656.50(2%)
644.75K to 631.37K
29-Aug-22 9:18 PM
View: 
Rojkjaer Lisa
Chief Medical Officer
Sunesis Pharmaceuticals Inc. (VIRX) 26-Aug-22Option Sale 2,190$4.01$8,785.84(5%)
46.3K to 44.1K
29-Aug-22 9:14 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 26-Aug-22Option Sale 3,655$4.02$14,679.20(4%)
86.03K to 82.38K
29-Aug-22 9:16 PM
View: 
Pomerantz Roger
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Aug-22Option Exercise 9,034----25%
36.14K to 45.17K
29-Aug-22 9:11 PM
View: 
Royston Ivor
CEO & President
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Aug-22Option Exercise 25,219----4%
619.53K to 644.75K
29-Aug-22 9:14 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 25-Aug-22Option Exercise 6,889----9%
79.14K to 86.03K
29-Aug-22 9:18 PM
View: 
Rojkjaer Lisa
Chief Medical Officer
Sunesis Pharmaceuticals Inc. (VIRX) 25-Aug-22Option Exercise 4,127----10%
42.17K to 46.3K
27-May-22 5:27 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 26-May-22Option Sale 3,596$1.90$6,836.36(4%)
82.74K to 79.14K
27-May-22 5:34 PM
View: 
Royston Ivor
CEO & President
Director
Sunesis Pharmaceuticals Inc. (VIRX) 26-May-22Option Sale 13,162$1.90$25,022.30(2%)
632.69K to 619.53K
27-May-22 5:32 PM
View: 
Rojkjaer Lisa
Chief Medical Officer
Sunesis Pharmaceuticals Inc. (VIRX) 26-May-22Option Sale 2,154$1.90$4,094.97(5%)
44.32K to 42.17K
27-May-22 5:34 PM
View: 
Royston Ivor
CEO & President
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-May-22Option Exercise 25,219----4%
607.47K to 632.69K
27-May-22 5:27 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 25-May-22Option Exercise 6,889----9%
75.85K to 82.74K
27-May-22 5:32 PM
View: 
Rojkjaer Lisa
Chief Medical Officer
Sunesis Pharmaceuticals Inc. (VIRX) 25-May-22Option Exercise 4,127----10%
40.2K to 44.32K
27-May-22 10:00 PM
View: 
Pomerantz Roger
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-May-22Option Exercise 9,034----33%
27.1K to 36.14K
01-Mar-22 9:12 PM
View: 
Rojkjaer Lisa
Chief Medical Officer
Sunesis Pharmaceuticals Inc. (VIRX) 28-Feb-22Option Sale 2,395$2.78$6,656.90(6%)
42.59K to 40.2K
01-Mar-22 9:13 PM
View: 
Royston Ivor
CEO & President
Director
Sunesis Pharmaceuticals Inc. (VIRX) 28-Feb-22Option Sale 14,635$2.78$40,678.00(2%)
622.11K to 607.47K
01-Mar-22 9:10 PM
View: 
Chevallard Daniel R.
CFO and COO
Sunesis Pharmaceuticals Inc. (VIRX) 28-Feb-22Option Sale 3,998$2.78$11,112.40(5%)
79.85K to 75.85K
01-Mar-22 9:12 PM
View: 
Rojkjaer Lisa
Chief Medical Officer
Sunesis Pharmaceuticals Inc. (VIRX) 25-Feb-22Option Exercise 4,127----11%
38.46K to 42.59K
01-Mar-22 9:13 PM
View: 
Royston Ivor
CEO & President
Director
Sunesis Pharmaceuticals Inc. (VIRX) 25-Feb-22Option Exercise 25,219----4%
596.89K to 622.11K